Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1977 Jul 9;2(6079):90–92. doi: 10.1136/bmj.2.6079.90

Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade.

A E Raine, T G Pickering
PMCID: PMC1630933  PMID: 17451

Abstract

The response to dynamic exercise was investigated in 21 patients receiving long-term treatment with beta-adrenoceptor antagonists and 22 controls. An electrocardiogram (ECG) and blood pressure were recorded before and after treadmill exercise, and plasma dopamine-beta-hydroxylase (DBH) activity was measured as an index of changes in sympathetic activity. Heart rate and blood pressure were lower at rest and throughout exercise in treated patients, although the pressor effect of exercise was not reduced. The ECG P-R interval was lengthened, and in addition the Q-T interval was prolonged. After exercise, plasma DBH activity was significantly increased in controls but not in treated patients. We conclude that long-term administration of beta-adrenergic blockers increases myocardial repolarisation time and reduces sympathetic nervous activity. These actions may contribute to the antiarrhythmic and hypotensive effects of long-term beta-blockade.

Full text

PDF
90

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coltart D. J., Shand D. G. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man. Br Med J. 1970 Sep 26;3(5725):731–734. doi: 10.1136/bmj.3.5725.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fitzgerald J. D. Beta-blockade and mechanisms of disease. Postgrad Med J. 1976;52 (Suppl 4):184–190. [PubMed] [Google Scholar]
  3. Geffen L. B., Livett B. G. Synaptic vesicles in sympathetic neurons. Physiol Rev. 1971 Jan;51(1):98–157. doi: 10.1152/physrev.1971.51.1.98. [DOI] [PubMed] [Google Scholar]
  4. Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study. Br Med J. 1975 Sep 27;3(5986):735–740. doi: 10.1136/bmj.3.5986.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Irving M. H., Britton B. J., Wood W. G., Padgham C., Carruthers M. Effects of beta adrenergic blockade on plasma catecholamines in exercise. Nature. 1974 Apr 5;248(448):531–533. doi: 10.1038/248531a0. [DOI] [PubMed] [Google Scholar]
  6. Lund-Johansen P. Hemodynamic changes at rest and during exercise in long-term beta-blocker therapy of essential hypertension. Acta Med Scand. 1974 Jan-Feb;195(1-2):117–121. doi: 10.1111/j.0954-6820.1974.tb08107.x. [DOI] [PubMed] [Google Scholar]
  7. Papp J. G., Williams E. M. A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function. Br J Pharmacol. 1969 Oct;37(2):391–399. doi: 10.1111/j.1476-5381.1969.tb10576.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Raine A. E., Chubb I. W. Long term beta-adrenergic blockade reduces tyrosine hydroxylase and dopamine beta-hydroxylase activities in sympathetic ganglia. Nature. 1977 May 19;267(5608):265–267. doi: 10.1038/267265a0. [DOI] [PubMed] [Google Scholar]
  9. Raine A. E., Williams E. M. Proceedings: Possible explanation for protective action of long-term beta-adrenoceptor blockade after myocardial infarction. Br Heart J. 1976 Aug;38(8):873–874. [PubMed] [Google Scholar]
  10. Schwartz P. J., Periti M., Malliani A. The long Q-T syndrome. Am Heart J. 1975 Mar;89(3):378–390. doi: 10.1016/0002-8703(75)90089-7. [DOI] [PubMed] [Google Scholar]
  11. Seides S. F., Josephson M. E., Batsford W. P., Weisfogel G. M., Lau S. H., Damato A. N. The electrophysiology of propranolol in man. Am Heart J. 1974 Dec;88(6):733–741. doi: 10.1016/0002-8703(74)90283-x. [DOI] [PubMed] [Google Scholar]
  12. Shand D. G., Nuckolls E. M., Oates J. A. Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112–120. doi: 10.1002/cpt1970111112. [DOI] [PubMed] [Google Scholar]
  13. Shinebourne E., Fleming J., Hamer J. Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease. Lancet. 1967 Dec 9;2(7528):1217–1220. doi: 10.1016/s0140-6736(67)90561-2. [DOI] [PubMed] [Google Scholar]
  14. Stern S., Eisenberg S. The effect of propranolol (Inderal) on the electrocardiogram of normal subjects. Am Heart J. 1969 Feb;77(2):192–195. doi: 10.1016/0002-8703(69)90350-0. [DOI] [PubMed] [Google Scholar]
  15. Tarazi R. C., Dustan H. P. Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol. 1972 May;29(5):633–640. doi: 10.1016/0002-9149(72)90164-6. [DOI] [PubMed] [Google Scholar]
  16. Ulrych M., Frohlich E. D., Dustan H. P., Page I. H. Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation. 1968 Mar;37(3):411–416. doi: 10.1161/01.cir.37.3.411. [DOI] [PubMed] [Google Scholar]
  17. Yanowitz F., Preston J. B., Abildskov J. A. Functional distribution of right and left stellate innervation to the ventricles. Production of neurogenic electrocardiographic changes by unilateral alteration of sympathetic tone. Circ Res. 1966 Apr;18(4):416–428. doi: 10.1161/01.res.18.4.416. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES